Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07058571 · ClinicalTrials.gov registry record · NA
Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention
A NA study of Blood Cancers, sponsored by VA Pittsburgh Healthcare System.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07058571 is a NA study of Blood Cancers that is actively recruiting participants, run by VA Pittsburgh Healthcare System. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07058571, a NA study of Blood Cancers, is actively recruiting participants, sponsored by VA Pittsburgh Healthcare System.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Background. This study aims to evaluate the effectiveness of a telehealth-mediated lifestyle intervention program tailored for veterans with blood cancer, focusing on improving health-related quality of life, mental health, and pain outcomes. The hypothesis posits that the telehealth-delivered program will lead to significant improvements in these areas, specifically targeting veterans undergoing treatment or in post-treatment phases. Objective. Recognizing the unique experiences of veterans, especially those in rural or underserved regions, this study seeks to provide insights into the feasibility and impact of telehealth-based lifestyle interventions for this distinct population. Methods. The pilot trial will enroll 30 veterans from the H. John Heinz III VA. Participants will complete baseline web-based surveys assessing demographics, occupational performance, and telehealth preparedness. The intervention comprises progressive resistance and aerobic exercises delivered via telehealth by a health coach, starting with a live supervised session followed by regular remote sessions. Each participant will engage in exercise sessions coordinated through the Veteran's Video Connect (VVC) application, with ongoing communication facilitated via email. This setup allows the health coach to adjust exercise intensity based on real-time symptom feedback. To address potential technology literacy biases, the VVCMatch assessment will categorize veterans as "technology prepared" or in need of additional education. Those requiring support will receive guidance on using the VVC app before starting the intervention. Additionally, participants will receive dietary consultations from the Leukemia and Lymphoma Society, independent of the research team. Outcome measures include assessments of symptoms, fatigue, function, mental health, and pain, along with evaluations of the intervention's usability through surveys on perceived usefulness and ease of use. These assessments aim to dete
Conditions Studied
Interventions
- OTHER EXERCISE TRAINING WITH OR WITHOUT MEDICATION
Study Locations (1)
Pennsylvania
- VA Pittsburgh Healthcare System - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-04-03 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07058571
The ClinicalTrials.gov registry entry for NCT07058571 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Pittsburgh Healthcare System, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Cancers appearing as the primary indexed condition, and to 1 intervention - of which EXERCISE TRAINING WITH OR WITHOUT MEDICATION is the first listed.
NCT07058571 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07058571 about?
NCT07058571 is a clinical study titled "Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention". Background. This study aims to evaluate the effectiveness of a telehealth-mediated lifestyle intervention program tailored for veterans with blood cancer, focusing on improving health-related quality of life, mental health, and pain outcomes. The hypothesis posits that the telehealth-delivered progr...
What is the current status of trial NCT07058571?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2015-04-03. Estimated completion is 2026-05-31.
What conditions does trial NCT07058571 study?
This clinical trial studies the following conditions: Blood Cancers.
What interventions are being tested in trial NCT07058571?
The interventions under investigation include: EXERCISE TRAINING WITH OR WITHOUT MEDICATION (OTHER).
Who is sponsoring clinical trial NCT07058571?
This trial is sponsored by VA Pittsburgh Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07058571 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Cancers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
RECRUITING · NA
-
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
RECRUITING · Phase 1
-
CIBMTR Research Database
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.